Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.160
0.00 (0.00%)
At close: Sep 11, 2026, 4:00 PM EDT
1.170
+0.010 (0.86%)
After-hours: Sep 11, 2026, 7:52 PM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $43.82 million as of September 11, 2026. Its market cap has decreased by -36.55% in one year.
Market Cap
43.82M
Enterprise Value
-39.12M
1-Year Change
-36.55%
Ranking
Category
Stock Price
$1.16
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $43.82M, a decrease of -92.22%. That is a compound annual growth rate of -62.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 43.82M | -27.96% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 48.04M |
| Impact BioMedical | 47.55M |
| Grace Therapeutics | 47.54M |
| Tevogen | 47.47M |
| Immutep | 46.50M |
| Veru Inc. | 42.63M |
| aTyr Pharma | 42.36M |
| Celularity | 41.54M |